By using this site, you agree to the Privacy Policy and Terms of Use.
Accept
GMJ NewsGMJ NewsGMJ News
  • Latest News
    • GMJ Briefs
  • Podcast & Media
    • Podcast Episodes
    • GMJ Audio
    • GMJ Videos
  • Research Digest
    • New Studies
    • Georgian Research
    • Data & Numbers
  • Policy & Systems
    • Health Policy
    • Quality & Safety
    • Migration & Health
    • Global Health
  • Practice
    • Clinical Updates
    • Case Discussions
    • Pharmacy & Prescribing
    • Ingredients A-Z
  • Perspectives
    • Editorial
    • Explainers
    • Voices
    • Letters
  • GMJ Articles
    • Vol. 1 Issue 2 (2026)
    • Vol. 1 Issue 1 (2026)
    • Pre-Launch Articles (2025)
  • Read the Journal →
  • About GMJ News
Notification Show More
Font ResizerAa
GMJ NewsGMJ News
Font ResizerAa
  • Latest News
    • GMJ Briefs
  • Podcast & Media
    • Podcast Episodes
    • GMJ Audio
    • GMJ Videos
  • Research Digest
    • New Studies
    • Georgian Research
    • Data & Numbers
  • Policy & Systems
    • Health Policy
    • Quality & Safety
    • Migration & Health
    • Global Health
  • Practice
    • Clinical Updates
    • Case Discussions
    • Pharmacy & Prescribing
    • Ingredients A-Z
  • Perspectives
    • Editorial
    • Explainers
    • Voices
    • Letters
  • GMJ Articles
    • Vol. 1 Issue 2 (2026)
    • Vol. 1 Issue 1 (2026)
    • Pre-Launch Articles (2025)
  • Read the Journal →
  • About GMJ News
Follow US
GMJ News > Drugs A-Z > Gabapentinoid > Gabapentin

Gabapentin

GMJ
Last updated: 02/06/2026 14:30
By
Prof. Giorgi Pkhakadze
Share
5 Min Read
SHARE
3 min read|593 words

What is Gabapentin?

Gabapentin is a prescription medication that belongs to a class of drugs called gabapentinoids. Originally developed as an anti-seizure medication, it is now widely used to treat nerve pain, epilepsy, and certain other neurological conditions. Despite its name suggesting a relationship to the neurotransmitter GABA, gabapentin works through a different mechanism involving calcium channels in nerve cells.

Uses

Gabapentin has several FDA-approved and commonly prescribed uses:

  • Epilepsy: Used as an add-on treatment for partial seizures in adults and children over 3 years old
  • Postherpetic neuralgia: Treats nerve pain that persists after a shingles infection
  • Diabetic neuropathy: Helps manage nerve pain caused by diabetes, though this is an off-label use
  • Restless leg syndrome: May be prescribed to reduce uncomfortable sensations and urges to move the legs
  • Fibromyalgia: Sometimes used off-label to help manage chronic widespread pain and associated symptoms

How it works

Gabapentin works by binding to specific calcium channels in nerve cells, reducing the release of excitatory neurotransmitters. This action helps calm overactive nerve signals that can cause seizures or transmit pain sensations. Unlike many other neurological medications, gabapentin does not directly interact with GABA receptors, despite its structural similarity to this neurotransmitter.

Side effects

Common side effects include:

Submit Your Paper
GMJ_Submit_Banner
  • Dizziness and drowsiness
  • Fatigue and weakness
  • Coordination problems (ataxia)
  • Blurred or double vision
  • Nausea and vomiting
  • Swelling in hands, feet, or legs
  • Weight gain
  • Tremor

Serious side effects to watch for:

  • Severe skin reactions or rash
  • Suicidal thoughts or behavior
  • Severe respiratory depression, especially when combined with opioids
  • Unusual changes in mood or behavior
  • Severe allergic reactions

Warnings and precautions

  • Kidney function: Dosage must be adjusted in patients with kidney impairment, as gabapentin is primarily eliminated through the kidneys
  • Pregnancy: Classified as pregnancy category C; should only be used if potential benefits outweigh risks to the fetus
  • Suicide risk: All antiepileptic drugs, including gabapentin, carry an FDA warning about increased risk of suicidal thoughts and behaviors
  • Respiratory depression: Can cause life-threatening breathing problems, especially when combined with opioids or other central nervous system depressants
  • Withdrawal: Should not be stopped abruptly; gradual tapering is necessary to prevent withdrawal seizures

Interactions

  • Opioid pain medications: Increases risk of severe respiratory depression and sedation
  • Antacids containing aluminum or magnesium: Can reduce gabapentin absorption; space doses at least 2 hours apart
  • Alcohol: Enhances sedative effects and increases risk of dangerous side effects
  • CNS depressants: Benzodiazepines, sleep medications, and muscle relaxants can increase drowsiness and coordination problems
  • Morphine: Can increase gabapentin levels in the blood, potentially leading to increased side effects
  • Naproxen: May increase gabapentin absorption and blood levels
  • Cimetidine: Can reduce gabapentin elimination, leading to higher blood levels
  • Phenytoin: Gabapentin may slightly reduce phenytoin levels in some patients

Check interactions with the GMJ Interaction Checker

Dosage

Gabapentin dosages vary significantly based on the condition being treated and individual patient factors. For epilepsy, typical starting doses range from 300mg three times daily, with gradual increases up to 1800-3600mg daily in divided doses. For postherpetic neuralgia, treatment usually begins with 300mg on day one, 600mg on day two (divided into two doses), then 900mg daily (divided into three doses), with further increases as needed up to 1800mg daily. Elderly patients and those with kidney problems require lower doses. All dosage adjustments should be made gradually over several days to weeks, and treatment plans should always be determined and monitored by a healthcare provider.

Sources: FDA DailyMed drug labels (public domain), BNF, WHO Essential Medicines List. This article is for informational purposes only and does not constitute medical advice. Always consult your healthcare provider before starting or stopping any medication.

Cite this page

GMJ News Desk. "Gabapentin." GMJ News — Georgian Medical Journal, 2 June 2026. https://news.gmj.ge/drug/gabapentin/

CC BY 4.0This work is licensed under Creative Commons Attribution 4.0 International (CC BY 4.0). You are free to share and adapt this content with attribution to GMJ News (news.gmj.ge).

Was this article helpful?

Share This Article
Facebook LinkedIn Bluesky Copy Link Print
GMJ
ByProf. Giorgi Pkhakadze
Follow:
Prof. Giorgi Pkhakadze, MD, MPH, PhD, is Editor-in-Chief of the Georgian Medical Journal and Chair of the Public Health Institute of Georgia (PHIG). He is Professor and Head of the Department of Social and Behavioural Sciences at David Tvildiani Medical University, and Secretary/Treasurer of the UEMS Section of Public Health. ORCID: 0000-0001-7609-4515.

Submit Your Paper →

Georgia's peer-reviewed open-access medical journal. No APC until January 2027.
Submit Manuscript →
Five Distinct Diabetes Development Patterns Identified Years Before Diagnosis

European study of 18,567 adults reveals five distinct metabolic pathways leading to…

Coeliac Disease Linked to Increased Death Risk and Cancer in Major US Study

Major US study of 60,000+ patients reveals coeliac disease patients face 39%…

Paralympic Doctor Returns to Sport as Blind Athlete with Guide Runner

Dr Oscar, a former Paralympic competitor turned medical professional, returns to sport…

Submit Your Paper to GMJ

No APC until January 2027.
Submit Manuscript →

You Might Also Like

Pregabalin

By
Prof. Giorgi Pkhakadze
02/06/2026
Facebook Twitter Youtube Instagram
Company
  • Privacy Policy
  • Contact US
  • GMJ Journal
  • Submit Manuscript
  • Editorial Team
  • Register at GMJ
  • Terms of Use

Subscribe to GMJ News — Click here

Join Community
© 2026 Georgian Medical Journal (GMJ). Published by the Public Health Institute of Georgia (PHIG). All rights reserved.
Welcome Back!

Sign in to your account

Username or Email Address
Password

Lost your password?

Not a member? Sign Up